Chatur, S., Vaduganathan, M., Fletcher, R., Perkovic, V., Heerspink, H., Arnott, C., . . . Neuen, B. (2025). Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials. urn:ISSN:1388-9842 ; urn:ISSN:1879-0844 ; European Journal of Heart Failure, 27, 6, 994-1002. https://doi.org/10.1002/ejhf.3586
Παραπομπή σε μορφή Chicago (17η εκδ.)Chatur, S., et al. "Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-level Pooled Analysis of the CANVAS and CREDENCE Trials." Urn:ISSN:1388-9842 ; Urn:ISSN:1879-0844 ; European Journal of Heart Failure, 27, 6, 994-1002 2025. https://doi.org/10.1002/ejhf.3586.
Παραπομπή σε μορφή MLA (9th εκδ.)Chatur, S., et al. "Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-level Pooled Analysis of the CANVAS and CREDENCE Trials." Urn:ISSN:1388-9842 ; Urn:ISSN:1879-0844 ; European Journal of Heart Failure, 27, 6, 994-1002, 2025, https://doi.org/10.1002/ejhf.3586.